Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma
-
Published:2018-12
Issue:6
Volume:4
Page:880-888
-
ISSN:2405-4569
-
Container-title:European Urology Focus
-
language:en
-
Short-container-title:European Urology Focus
Author:
Priemer David S.,
Wang Mingsheng,
Zhang Shaobo,
Lopez-Beltran Antonio,
Kouba Erik,
Montironi Rodolfo,
Davidson Darrell D.ORCID,
MacLennan Gregory T.,
Wang Lisha,
Osunkoya Adeboye O.,
Deng Youping,
Emerson Robert E.,
Cheng Liang
Reference44 articles.
1. Bladder pathology;Cheng,2012
2. Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics;Kouba;Endocr Pathol,2016
3. Small cell carcinoma of the urinary bladder. a clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases;Blomjous;Cancer,1989
4. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma;Cheng;Am J Pathol,2005
5. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome;Allory;Eur Urol,2014
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献